Pfizer Inc. (NYSE:PFE) has issued its financial guidance for the full year 2025, projecting revenue growth between $61 billion and $64 billion, representing a flat 5% operational increase from the midpoint of its 2024 guidance. The pharmaceutical giant also forecast